Kelley Hogan

Kelley Hogan has extensive experience in market access and pharmaceutical sales. Kelley is currently working as the Director of Market Access at CeQur since April 2022. Previously, they worked at Emergent BioSolutions where they held the roles of National Account Director from June 2021 to April 2022 and Market Access Director from March 2020 to June 2021. Prior to that, Kelley was the Director of Market Access at Duchesnay USA from June 2017 to March 2020. Kelley also had a long tenure at Novo Nordisk, serving as a Manager of Market Access-National Accounts from July 2016 to May 2017, a Senior Institutional Diabetes Care Specialist from August 2012 to July 2016, and an Endocrine Diabetes Care Specialist from an unknown start date to July 2016. Kelley began their career in pharmaceutical sales at Johnson & Johnson from an unknown start date to 2002.

Kelley Hogan obtained a Bachelor of Science degree in Secondary Education-Biology from West Virginia University. Kelley pursued this course of study from 1994 to 1998.